PolyPid, which develops an antibiotic coating for bone repair, has filed with the SEC for an initial public offering on the NASDAQ in which it hopes to raise $24 million. This could leave the company with a valuation of as much as $100 million. The number of shares to be...
Read more
Blog
Can-Fite Liver Therapy Patent
Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), announced the United States Patent and Trademark Office has issued a patent to the Company which covers its drug candidate, CF102, in the treatment of liver regeneration and function following liver surgery. The issued patent # 8,846,635 is titled, “Method for inducing...
Read more
Micromedic in Beijing Trial
Micromedic Technologies which specializes in the development and commercialization of cancer diagnostic products has conducted the trial of its CellDetect for detecting cervical cancer at the Beijing Military Hospital. The company said that the tests showed that the product marks cancer cells, thereby rendering the diagnostic process more effective. It...
Read more
IonMed Surgical Closure Gets CE
IonMed has received CE mark clearance for its Bioweld1™ cold plasma system for surgical incision closure. Bioweld1 is the first system in the rapidly emerging field of plasma medicine designed for use in operating room settings as an alternative to surgical staples, sutures, and sealants. The patented Bioweld1 system combines...
Read more
LapSpace Laparoscopic Trials
LapSpace Medical has completed a series of successful procedures, utilizing its inflatable laparoscopic retractor, on patients in the United States and India. The surgeries were performed by Dr. Bruce Ramshaw and Dr. Surendra Ugale, both world-renowned laparoscopic surgeons. LapSpace’s device was used to retract the intestines during laparoscopic abdominal surgery....
Read more